
Utah Medical Products, Inc. (UTMD) Market Cap
Utah Medical Products, Inc. has a market capitalization of $226.3M.
Financials based on reported quarter end 2025-12-31
Price: $70.65
โฒ 1.10 (1.58%)
Market Cap: 226.34M
NASDAQ ยท time unavailable
CEO: Kevin L. Cornwell
Sector: Healthcare
Industry: Medical - Instruments & Supplies
IPO Date: 1999-03-08
Website: https://www.utahmed.com
Utah Medical Products, Inc. (UTMD) - Company Information
Market Cap: 226.34M ยท Sector: Healthcare
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Analyst Sentiment
Based on 0 ratings
Consensus Price Target
No data available
Price & Moving Averages
Related Companies in Healthcare

AVIDITY BIOSCIENCES INC (RNA)
Healthcare
$0.22B
Mkt Cap

ANTERIS TECHNOLOGIES GLOBAL CORP (AVR)
Healthcare
$0.22B
Mkt Cap

ANIKA THERAPEUTICS INC (ANIK)
Healthcare
$0.23B
Mkt Cap

SIGHT SCIENCES INC (SGHT)
Healthcare
$0.22B
Mkt Cap

COHERUS ONCOLOGY INC (CHRS)
Healthcare
$0.23B
Mkt Cap

ORASURE TECHNOLOGIES INC (OSUR)
Healthcare
$0.22B
Mkt Cap
Fundamentals Overview
๐ AI Financial Analysis
Powered by StockMarketInfo"UTMD reported revenue of $9.044M and a net income of $2.565M, translating to an earnings per share (EPS) of $0.77, indicating a profitable operation despite modest revenue. The company holds total assets of $122.542M against total liabilities of only $3.274M, leading to a robust equity position of $119.268M and negative net debt of -$85.531M, reflecting strong financial health. The operating cash flow stands at $3.878M, and free cash flow is a solid $3.851M, showcasing effective cash generation capabilities. Dividends paid amounted to $0.988M in the recent period, aligning with a commitment to returning value to shareholders. With a market price of $63.8, UTMD has experienced a 1-year price appreciation of 11.85%, though it remains below the 20% threshold for higher assessment of shareholder returns. Overall, while the company shows strong fundamentals and profitability, its revenue growth and shareholder return metrics are notable areas for attention."
Revenue Growth
Revenue growth is present, but minimal compared to overall potential.
Profitability
Strong net income relative to revenue indicates solid profitability.
Cash Flow Quality
Consistent operating and free cash flow shows healthy liquidity position.
Leverage & Balance Sheet
Very low liabilities relative to assets and negative net debt indicate a strong balance sheet.
Shareholder Returns
While dividends are present, price appreciation hasnโt exceeded 20%.
Analyst Sentiment & Valuation
No current price targets but price stability reflects cautious sentiment.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.